The Net Margin of Eiger BioPharmaceuticals Inc (EIGR) is -475.26%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2022-12-31 | -475.26% |
2021-12-31 | -279.41% |